Results from clinical trials suggest that such drugs could have potential for the treatment of asthma, which is one of the most chronic inflammatory pulmonary diseases in the world and often linked to both type 2 diabetes and obesity (Wu, Stokes Peebles)
Medical Disclaimer This guide is for educational and informational purposes only
GLP-1 receptor agonists significantly impair taste function
The SURMOUNT-1 study was a placebo-controlled 72-week trial in obese subjects that randomized 2,539 participants without diabetes into four equally large study arms with placebo or one of the three tirzepatide doses (5, 10, or 15 mg once weekly)
Less common or serious side effects can include: Gallbladder issues or pancreatitis (associated with certain GLP-1 medications) Mood changes or insomnia (especially with bupropion-containing medications) Elevated blood pressure or heart rate (phentermine-related) Allergic reactions (rare, but possible with any medication) Medical Weight Loss is not suitable for everyone
Eating well on a GLP-1 isnt just about choosing healthy foods